Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Sjögren’s symptom clusters may identify treatment options

Publish date:: November 12, 2020

Key clinical point: Symptom-based clusters can aid in Sjögren’s syndrome research.

Major finding: Four symptom clusters ranging from low to high symptom burden were verified.

Study details: A hierarchical cluster analysis of data on 2,961 patients with Sjögren’s syndrome.

Disclosures: The study was supported by grants from the National Institutes of Health and the University of Wisconsin. Dr. McCoy disclosed consulting fees from Novartis and Bristol-Myers Squibb.

Citation:

McCoy SS et al. Arthritis Rheumatol. 2020;72(suppl 10), Abstract 1504.

This Week's Must Reads

Osteoporosis prevalence in PsA similar to general population,

Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases,

Weight loss may be paramount lifestyle change in preventing gout,

Gut microbiome influences response to methotrexate in new-onset RA patients,

Early treatment of RA with DMARDs promotes sustained remission,

Must Reads in Lupus & Connective Tissue Diseases

High-need, high-cost lupus patients described for first time,

Slow taper off antimalarial is best to avoid lupus flare during remission,

Sjögren’s symptom clusters may identify treatment options,

Transcutaneous VNS on the ear shows positive effects in lupus pilot trial,

ASSET extension supports abatacept as treatment for diffuse cutaneous systemic sclerosis,